N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

62 API Suppliers, 34 USDMF, 1 JDMF, 8 EU WC, 8 KDMF, 21 NDC API, 41 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

33 Intermediate Suppliers

33 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

101 FDF Dossiers, 48 FDA Orange Book, 8 Europe, 20 Canada, 2 Australia, 2 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 30MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 DFE Pharma, 3 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 8 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 13 Disintegrants & Superdisintegrants, 12 Direct Compression, 10 Granulation, 9 Lubricants & Glidants, 9 Thickeners and Stabilizers, 7 Co-Processed Excipients, 3 Controlled & Modified Release, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 2 Taste Masking, 2 Coating Systems & Additives, 1 Emulsifying Agents, 1 Parenteral, 1 Film Formers & Plasticizers